• Glycemic deregulation• Insulin resistance• Increase in leptin levels• Increased cholesterol concentration• Sialorrhea (secondary to VIP interaction with muscarinic receptor)• Ovarian mitochondrial dysfunction. This evidence concerns the gene VIP and Insulin resistance.